Survey of expert opinions and related recommendations regarding bridging therapy using hypomethylating agents followed by allogeneic transplantation for high-risk MDS-Reference-Cited by-同舟云学术

Survey of expert opinions and related recommendations regarding bridging therapy using hypomethylating agents followed by allogeneic transplantation for high-risk MDS

Published:2015-08 Issue:2 Volume:95 Page:243-250
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Sohn Sang Kyun,Moon Joon Ho

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference36 articles.

1. NCCN clinical practice guidelines in oncology: myelodysplastic syndromes;Greenberg;J Natl Compr Canc Netw,2011

2. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome;Cutler;Blood,2004

3. Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes;Oran;Clin Lymphoma Myeloma Leuk,2013

4. The euphoria of hypomethylating agents in MDS and AML: is it justified;Sekeres;Best Pract Res Clin Haematol,2013

5. Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes;Steensma;Best Pract Res Clin Haematol,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome;The Korean Journal of Internal Medicine;2018-11-01

2. Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia;Acta Haematologica;2017

3. The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome;Clinical oncohematology;2017

4. Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes;Annals of Hematology;2016-08-17

5. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?;Mycoses;2016-03-30